Postnatal Growth Restriction
3
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Targeted Fortification
Research Leaders
5 sponsors active, led by University of Alabama at Birmingham
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Targeted Nutrition for Moderate to Late Preterm Infants
Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia
Human Milk-derived Fortification in Preterm Infants
Research Network
Common Treatments
- Targeted Fortification1
- Highvolume Breastmilk1
- Bovine Milkderived Hmf1
- Enfamil Liquid Human Milk Fortifier1
- Human Milkderived Hmf1
Active Sponsors
- University of Alabama at Birmingham1
- Centre for Infectious Disease Research in Zambia1
- Chiesi Foundation1
- University of Calgary1
- Loma Linda University1
Top Investigators
Loma Linda University
University of Calgary
University of Alabama at Birmingham
University of Alabama at Birmingham
University of Alabama at Birmingham
Related Conditions
- Breastmilk Collection1
- Premature Birth1
- Necrotizing Enterocolitis1